described that, in CML patients, 6 months of IM treatment resulted in the increase of BM adipocytes and in a 3-fold up-regulation of adiponectin serum levels [174]. This evidence concerns the gene ADIPOQ and chronic myelogenous leukemia, BCR-ABL1 positive.